Back to search
Pulmonary Mucormycosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Mucormycosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Mucormycosis trials you may qualify forInvasive pulmonary fungal infections caused by Mucorales are rare but severe and rapidly progressive, affecting immunocompromised patients. The role of chest im…
Pulmonary mucormycosis is a serious illness with high morbidity and mortality (approximately 57%). Surgery and antifungal therapy are central in the management…
The project intends to carry out a retrospective study on the epidemiology, predisposing factors, clinical manifestations, diagnosis, treatment, prognosis and e…
Pulmonary mucormycosis (PM) poses a substantial clinical challenge, particularly among immunocompromised patients. The aim of the study is to determine the effe…
Evaluation of the effectiveness and safety of transbronchoscopic local precision infusion of amphotericin B + transoral nebulized inhalation of amphotericin B +…